These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16718754)

  • 1. Cholecystokinin hyperresponsiveness in functional dyspepsia.
    Chua AS; Keeling PW
    World J Gastroenterol; 2006 May; 12(17):2688-93. PubMed ID: 16718754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.
    Chua AS; Keeling PW; Dinan TG
    World J Gastroenterol; 2006 Mar; 12(9):1329-35. PubMed ID: 16552797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serotonergic and noradrenergic receptors in functional dyspepsia.
    O'Mahony S; Dinan TG; Keeling PW; Chua AS
    World J Gastroenterol; 2006 May; 12(17):2681-7. PubMed ID: 16718753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide.
    Schwizer W; Borovicka J; Kunz P; Fraser R; Kreiss C; D'Amato M; Crelier G; Boesiger P; Fried M
    Gut; 1997 Oct; 41(4):500-4. PubMed ID: 9391249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and exogenous cholecystokinin may reduce food intake by different mechanisms.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Aug; 253(2 Pt 2):R379-82. PubMed ID: 3618836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral apelin-13 administration inhibits gastrointestinal motor functions in rats: The role of cholecystokinin through CCK
    Bülbül M; Sinen O; Birsen İ; Izgüt-Uysal V
    Neuropeptides; 2017 Jun; 63():91-97. PubMed ID: 28012561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis.
    Keohane J; Quigley EM
    World J Gastroenterol; 2006 May; 12(17):2672-6. PubMed ID: 16718751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats.
    Raybould HE; Taché Y
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G242-6. PubMed ID: 3136661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C; Karaus M
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fat and cholecystokinin in functional dyspepsia.
    Fried M; Feinle C
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i54-7. PubMed ID: 12077066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia.
    Ogiso K; Asakawa A; Amitani H; Inui A
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():67-72. PubMed ID: 21443713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological effect of cholecystokinin on gastric emptying of liquid in functional dyspepsia.
    Cote F; Pare P; Friede J
    Am J Gastroenterol; 1995 Nov; 90(11):2006-9. PubMed ID: 7485011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
    Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cholecystokinin in regulation of gastrointestinal motor functions.
    Meyer BM; Werth BA; Beglinger C; Hildebrand P; Jansen JB; Zach D; Rovati LC; Stalder GA
    Lancet; 1989 Jul; 2(8653):12-5. PubMed ID: 2567793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.